Internal Medicine 1013 - Internal Medicine Alert - Jul 15, 2006

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/06. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of this issue.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Stephen Brunton, MD
Clinical Professor
University of California, Irvine

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Associate Editors
Allan J. Wilke, MD
Residency Program Director
Associate Professor of Family Medicine
University of Alabama
Birmingham School of Medicine
Huntsville Regional Medical Campus
Huntsville

Joseph E. Scherger, MD, MPH
Clinical Professor
University of California
San Diego

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

William T. Elliott, MD, FACP
Chair
Formulary Committee
Northern California Kaiser Permanente;
Asst. Clinical Professor of Medicine
University of California
San Francisco

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor
Assistant Director
Family Practice Residency Program
University of Florida

Author
Matthew E. Fink, MD
Vice Chairman
Professor of Clinical Neurology
Weill Cornell Medical College
Chief
Division of Stroke and Critical Care Neurology
NewYork-Presbyterian Hospital

Subjects:

  • COPD, PE, or Both?
  • Does an MRI Diagnose Multiple Sclerosis?
  • Which Non-Invasive Test is Best for the Diagnosis of Clinically Significant Carotid Artery Stenosis?
  • Varenicline Tartrate Tablets (Chantix™)
  • Clinical Briefs
  • ECG Review: RBBB with a Twist

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens

Financial Disclosure:

Internal Medicine Alert's Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca, and serves on the speaker's bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil. Peer reviewer Gerald Roberts, MD, associate editors Allan J. Wilke, MD, Joseph E. Scherger, MD, MPH, James Chan, PharmD, PhD, William T. Elliott, MD, FACP, and Ken Grauer, MD, and author Matthew E. Fink, MD report no financial relationship to this field of study. Associate editor Louis Kuritzky, MD is on the speaker’s bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2006 AHC Media. All rights reserved.